Sphingolipids and complement components signaling in glioblastoma

Sphingolipids and complement components signaling in glioblastoma. A zoomed coronal plane view of a glioblastoma tumor and its microenvironment. (A) In glioblastoma tumor, the US28 receptor stimulates SPHK1 in the sphingolipid metabolic pathway to release S1P, which exits the cell through an S1P transporter, like SPNS2, to engage with S1PR1. S1P/S1PR1 signaling activates AKT, JAK2, STAT3, and cMYC pathways to promote glioblastoma pro-survival phenotype. A study has shown that the S1P-S1PR1 signaling pathway activates AKT, which in turn triggers intracellular C3 cleavage into biologically active C3a and C3b via CTSL protease [56]. This activation enables PPIL1-C3b binding that induces NLRP3 inflammasome. The result of this process is the development of metastatic phenotype in melanoma, breast, and head and neck cancers. This mechanism may also be applicable to glioblastoma. The mitochondria-associated protein, Bcl2L13, is upregulated in glioblastoma and binds CerS2 and CerS6, inhibiting apoptosis by blocking ceramide synthesis. (B) Exposing glioblastoma to TGF-β increases mRNA expression levels for C3aR, C3, CTSL, and growth factors. (C) In the tumor microenvironment, mesenchymal stem-like cells (MSLCs) secrete the C5a anaphylatoxin, which binds to the C5aR expressed on glioblastoma tumors. C5a–C5aR1 signaling stimulates a metastatic phenotype on glioblastoma by increasing ZEB1 expression via the p38 MAPK pathway. FTY720 treatment internalizes CXCR4 on glioma-associated microglia to inhibit the metastatic phenotype of glioblastoma cells. In tumor-associated macrophages (TAMs), the nuclear factor of activated T cells-1 (NFAT1) stimulates C3 transcriptional activity and increases C3a secretion, which binds C3aR in an autocrine manner. In a positive feedback loop, C3a-C3aR signaling activates the Ca2+-NFAT1 pathway, which induces M2-like TAMs and promotes glioma stem cells (GSCs) malignant phenotype. Abbreviations: SPHK1, sphingosine Kinase 1; S1P, sphingosine-1-phosphate; SPNS2, spinster homologue 2, S1PR1, sphingosine-1-phosphate receptor 1; CTSL, cathepsin L; PPIL1, Peptidylprolyl Isomerase Like 1, NLRP3, NLR Family Pyrin Domain Containing 3; ZEB1, Zinc finger E-box binding homeobox 1
Sphingolipids and complement components signaling in glioblastoma

Publication

Sphingolipid Signaling and Complement Activation in Glioblastoma: A Promising Avenue for Therapeutic Intervention (2024) Alhaji H. Janneh, et al. Biochem (Basel). 2024 Jun 10;4(2). Figure: F4.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates S1PR1 S1PR1 ncbigene_symbol S1PR1 1901
Homo sapiens Primates SPNS2 SPNS2 ncbigene_symbol SPNS2 124976
Homo sapiens Primates S1P S1P ncbigene_synonym MBTPS1 8720
Homo sapiens Primates -AKT AKT ncbigene_synonym AKT1 207
Homo sapiens Primates -AKT AKT famplex_relations AKT2 208
Homo sapiens Primates -AKT AKT famplex_relations AKT3 10000
Homo sapiens Primates JAK2 JAK2 ncbigene_symbol JAK2 3717
Homo sapiens Primates STAT3 STAT3 ncbigene_symbol STAT3 6774
Homo sapiens Primates CMYC CMYC ncbigene_synonym MYC 4609
Homo sapiens Primates SPHK SPHK ncbigene_synonym SPHK1 8877
Homo sapiens Primates SPHK SPHK famplex_relations SPHK2 56848
Homo sapiens Primates (Bcl2L13 BCL2L13 ncbigene_symbol BCL2L13 23786
Homo sapiens Primates C5a C5A ncbigene_synonym C5 727
Homo sapiens Primates C5a C5A ncbigene_synonym C5AR1 728
Homo sapiens Primates p38 P38 ncbigene_synonym CRK 1398
Homo sapiens Primates p38 P38 ncbigene_synonym MAPK14 1432
Homo sapiens Primates p38 P38 ncbigene_synonym MAPK1 5594
Homo sapiens Primates p38 P38 ncbigene_synonym AIMP2 7965
Homo sapiens Primates p38 P38 ncbigene_synonym GRAP2 9402
Homo sapiens Primates p38 P38 ncbigene_synonym AHSA1 10598
Homo sapiens Primates p38 P38 ncbigene_synonym POLDIP2 26073
Homo sapiens Primates p38 P38 famplex_relations MAPK11 5600
Homo sapiens Primates p38 P38 famplex_relations MAPK12 6300
Homo sapiens Primates p38 P38 famplex_relations MAPK13 5603
Homo sapiens Primates MAPK MAPK famplex_relations MAPK3 5595
Homo sapiens Primates MAPK MAPK famplex_relations MAPK8 5599
Homo sapiens Primates MAPK MAPK famplex_relations MAPK9 5601
Homo sapiens Primates MAPK MAPK famplex_relations MAPK10 5602
Homo sapiens Primates ZEB1 ZEB1 ncbigene_symbol ZEB1 6935
Homo sapiens Primates PPIL1 PPIL1 ncbigene_symbol PPIL1 51645
Homo sapiens Primates C3b→ C3B ncbigene_synonym C3 718
Homo sapiens Primates C3b→ C3B ncbigene_synonym ERVK-3 100862689
Homo sapiens Primates NLRP3 NLRP3 ncbigene_symbol NLRP3 114548
Homo sapiens Primates CTSL CTSL ncbigene_symbol CTSL 1514
Homo sapiens Primates C3a C3A ncbigene_synonym ERVK-2 100616100
Homo sapiens Primates CXCR4 CXCR4 ncbigene_symbol CXCR4 7852
Homo sapiens Primates C3aR C3AR ncbigene_synonym C3AR1 719
Homo sapiens Primates NFAT1 NFAT1 ncbigene_synonym NFATC2 4773

Chemical mentions

Word Match MeSH Name ChEBI
S1P S1P (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate chebi:37550
Sphingosine SPHINGOSINE (2R,3S,4Z)-2-aminooctadec-4-ene-1,3-diol chebi:45719
Ceramides ceramides a ceramide chebi:17761
Nucleus nucleus nucleus chebi:33252
FTY720 FTY720 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol chebi:63115
Ca2+ Ca2+ Ca(2+) chebi:29108

Disease mentions

Word Match MeSH Name DOID
Glioblastoma glioblastoma glioblastoma DOID:3068
Cancer cancer cancer DOID:162